Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMW0Y75)

Drug Name
ISIS 150454 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMW0Y75

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting SOD1 messenger RNA (SOD1 mRNA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-SOD1 DMV1BTP Amyotrophic lateral sclerosis 8B60.0 Phase 1 [2]
ISIS 150463 DMFUM62 Discovery agent N.A. Investigative [1]
ISIS 150450 DMMBW13 Discovery agent N.A. Investigative [1]
ISIS 150451 DM1DCFP Discovery agent N.A. Investigative [1]
ISIS 150452 DMQE7BH Discovery agent N.A. Investigative [1]
ISIS 150464 DM1IC54 Discovery agent N.A. Investigative [1]
ISIS 150453 DMKCG41 Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
SOD1 messenger RNA (SOD1 mRNA) TTP9K3Q SODC_HUMAN Not Available [1]

References

1 US patent application no. 7,132,530, Antisense modulation of superoxide dismutase 1, soluble expression.
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).